GoodRx Holdings, Inc. Business Acquisition, Pro Forma Net Income (Loss)
GoodRx Holdings, Inc. (GDRX) reported Business Acquisition, Pro Forma Net Income (Loss) of -$40.90 million for the 12-month period ending 2022-12-31, per its 10-K filed 2025-02-27.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss · last filed 2025-02-27
- GoodRx Holdings, Inc. business acquisition, pro forma net income (loss) for the quarter ending 2022-12-31 was -$1.97M.
- GoodRx Holdings, Inc. business acquisition, pro forma net income (loss) for the quarter ending 2022-09-30 was -$41.73M.
- GoodRx Holdings, Inc. business acquisition, pro forma net income (loss) for the quarter ending 2022-06-30 was -$2.33M, a 110.10% decline year-over-year.
- GoodRx Holdings, Inc. business acquisition, pro forma net income (loss) for the quarter ending 2022-03-31 was $5.14M.
- GoodRx Holdings, Inc. business acquisition, pro forma net income (loss) for fiscal 2022 was -$40.90M.
- GoodRx Holdings, Inc. business acquisition, pro forma net income (loss) for fiscal 2021 was -$59.40M.
| Period end | Business Acquisition, Pro Forma Net Income (Loss) 3 month | Business Acquisition, Pro Forma Net Income (Loss) 6 month | Business Acquisition, Pro Forma Net Income (Loss) 9 month | Business Acquisition, Pro Forma Net Income (Loss) 12 month |
|---|---|---|---|---|
| 2022-12-31 | -$1.97M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | -$43.71M derived: sum of 2 quarters · filed 2025-02-27 | -$46.04M derived: sum of 3 quarters · filed 2025-02-27 | -$40.90M 10-K · filed 2025-02-27 |
| 2022-09-30 | -$41.73M 10-Q · filed 2023-11-09 | -$44.07M derived: sum of 2 quarters · filed 2023-11-09 | -$38.93M 10-Q · filed 2023-11-09 | -$86.78M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-06-30 | -$2.33M 10-Q · filed 2023-08-09 | $2.81M 10-Q · filed 2023-08-09 | -$45.05M derived: sum of 3 quarters · filed 2024-02-29 | -$71.77M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-03-31 | $5.14M 10-Q · filed 2023-05-10 | -$42.72M derived: sum of 2 quarters · filed 2024-02-29 | -$69.44M derived: sum of 3 quarters · filed 2024-02-29 | -$46.32M derived: sum of 4 quarters · filed 2024-02-29 |
| 2021-12-31 | -$47.86M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | -$74.58M derived: sum of 2 quarters · filed 2024-02-29 | -$51.46M derived: sum of 3 quarters · filed 2024-02-29 | -$59.40M 10-K · filed 2024-02-29 |
| 2021-09-30 | -$26.72M 10-Q · filed 2022-11-09 | -$3.60M derived: sum of 2 quarters · filed 2022-11-09 | -$11.54M 10-Q · filed 2022-11-09 | |
| 2021-06-30 | $23.12M 10-Q · filed 2022-08-09 | $15.18M 10-Q · filed 2022-08-09 |